Estrogen blocks neurotoxic effects of β-amyloid (1–42) and induces neurite extension on B103 cells

Abstract

Clinical studies have shown that estrogen replacement therapy is associated with reduced risk of Alzheimer's disease (AD). We tested whether or not estrogen blocks neurotoxic effects of β-amyloid (1–42) (A β 1–42) on cultured B103 cells. A β 1–42 (1 μM) induced typical necrotic cell death, as revealed by light and electron microscopic examinations. Co-administration of estrogen not only blocked A β 1–42 toxicity to a large degree, but also enhanced neurite extension. Pretreatment with estrogen was even more effective in blocking A β 1–42 toxicity. When added 18 h after the beginning of A β 1–42 treatment, estrogen was still effective in halting the progress of cell death and enhancing neurite extension. The protection against A β 1–42-induced neuronal death by estrogen was unlikely due to a blockade of lipid peroxidation injury, since estrogen completely failed to attenuate ferrous chloride-induced cell death. These results demonstrate that estrogen blocks A β 1–42-induced neurotoxicity and enhances neurite extension on B103 cells, both of which may well be underlying mechanisms of beneficial effects of estrogen in AD.